Skip to main content
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · XENE ISIN · CA98420N1050 LEI · 549300XV44Q9Z1MIPQ03 US Manufacturing
Open in API
Filings indexed 746 across all filing types
Latest filing 2023-06-02 Director's Dealing
Country CA Canada
Listing US XENE

About Xenon Pharmaceuticals Inc.

https://www.xenon-pharma.com/

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to the discovery, clinical development, and commercialization of therapeutics for neurological and psychiatric disorders. The company leverages its expertise in human genetics and a deep understanding of ion channel biology to develop medicines that modulate ion channels, targeting the central and peripheral nervous systems. Its late-stage pipeline includes azetukalner, an investigational candidate being developed for the treatment of epilepsy and depression.

Recent filings

Filing Released Lang Actions
4
Director's Dealing
2023-06-02 English
4
Director's Dealing
2023-06-02 English
4
Director's Dealing
2023-06-02 English
4
Director's Dealing
2023-06-02 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated June 1, 2023, by Xenon Pharmaceuticals Inc. The key content is the submission of matters to a vote of security holders at the 2023 Annual Meeting of Shareholders. It details the voting results on four proposals: election of directors, advisory vote on executive compensation (say-on-pay), appointment of auditor, and remuneration of auditor. The document provides specific vote counts and outcomes, which are official results from shareholder votes at a general meeting. There is no indication that this is a full annual report, proxy statement, or other type of filing. The presence of detailed voting results aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4699 characters, which is sufficient to contain substantive voting results rather than just an announcement of a report. Therefore, the correct classification is DVA with high confidence.
2023-06-02 English
4
Director's Dealing
2023-06-02 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.